Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dolby Laboratories (DLB) Shares Outstanding (Diluted Average) (2016 - 2025)

Dolby Laboratories (DLB) has disclosed Shares Outstanding (Diluted Average) for 17 consecutive years, with $96.5 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding (Diluted Average) fell 0.65% year-over-year to $96.5 million, compared with a TTM value of $96.5 million through Dec 2025, down 0.65%, and an annual FY2025 reading of $97.5 million, changed 0.16% over the prior year.
  • Shares Outstanding (Diluted Average) was $96.5 million for Q4 2025 at Dolby Laboratories, down from $97.5 million in the prior quarter.
  • Across five years, Shares Outstanding (Diluted Average) topped out at $104.6 million in Q2 2021 and bottomed at $96.5 million in Q4 2025.
  • Average Shares Outstanding (Diluted Average) over 5 years is $99.5 million, with a median of $97.5 million recorded in 2025.
  • The sharpest move saw Shares Outstanding (Diluted Average) rose 2.51% in 2021, then dropped 6.51% in 2022.
  • Year by year, Shares Outstanding (Diluted Average) stood at $103.8 million in 2021, then dropped by 6.51% to $97.0 million in 2022, then increased by 0.4% to $97.4 million in 2023, then dropped by 0.3% to $97.1 million in 2024, then dropped by 0.65% to $96.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Diluted Average) for DLB at $96.5 million in Q4 2025, $97.5 million in Q3 2025, and $96.9 million in Q2 2025.